These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2127 related articles for article (PubMed ID: 32240634)

  • 1. Estimates of the severity of coronavirus disease 2019: a model-based analysis.
    Verity R; Okell LC; Dorigatti I; Winskill P; Whittaker C; Imai N; Cuomo-Dannenburg G; Thompson H; Walker PGT; Fu H; Dighe A; Griffin JT; Baguelin M; Bhatia S; Boonyasiri A; Cori A; Cucunubá Z; FitzJohn R; Gaythorpe K; Green W; Hamlet A; Hinsley W; Laydon D; Nedjati-Gilani G; Riley S; van Elsland S; Volz E; Wang H; Wang Y; Xi X; Donnelly CA; Ghani AC; Ferguson NM
    Lancet Infect Dis; 2020 Jun; 20(6):669-677. PubMed ID: 32240634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of SARS-CoV-2 mortality during the early stages of an epidemic: A modeling study in Hubei, China, and six regions in Europe.
    Hauser A; Counotte MJ; Margossian CC; Konstantinoudis G; Low N; Althaus CL; Riou J
    PLoS Med; 2020 Jul; 17(7):e1003189. PubMed ID: 32722715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolving epidemiology and transmission dynamics of coronavirus disease 2019 outside Hubei province, China: a descriptive and modelling study.
    Zhang J; Litvinova M; Wang W; Wang Y; Deng X; Chen X; Li M; Zheng W; Yi L; Chen X; Wu Q; Liang Y; Wang X; Yang J; Sun K; Longini IM; Halloran ME; Wu P; Cowling BJ; Merler S; Viboud C; Vespignani A; Ajelli M; Yu H
    Lancet Infect Dis; 2020 Jul; 20(7):793-802. PubMed ID: 32247326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Data-based analysis, modelling and forecasting of the COVID-19 outbreak.
    Anastassopoulou C; Russo L; Tsakris A; Siettos C
    PLoS One; 2020; 15(3):e0230405. PubMed ID: 32231374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early epidemiological assessment of the transmission potential and virulence of coronavirus disease 2019 (COVID-19) in Wuhan City, China, January-February, 2020.
    Mizumoto K; Kagaya K; Chowell G
    BMC Med; 2020 Jul; 18(1):217. PubMed ID: 32664866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal estimates of case-fatality rate for COVID-19 outbreaks in Canada and the United States.
    Abdollahi E; Champredon D; Langley JM; Galvani AP; Moghadas SM
    CMAJ; 2020 Jun; 192(25):E666-E670. PubMed ID: 32444481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating the infection-fatality risk of SARS-CoV-2 in New York City during the spring 2020 pandemic wave: a model-based analysis.
    Yang W; Kandula S; Huynh M; Greene SK; Van Wye G; Li W; Chan HT; McGibbon E; Yeung A; Olson D; Fine A; Shaman J
    Lancet Infect Dis; 2021 Feb; 21(2):203-212. PubMed ID: 33091374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating the infection and case fatality ratio for coronavirus disease (COVID-19) using age-adjusted data from the outbreak on the Diamond Princess cruise ship, February 2020.
    Russell TW; Hellewell J; Jarvis CI; van Zandvoort K; Abbott S; Ratnayake R; ; Flasche S; Eggo RM; Edmunds WJ; Kucharski AJ
    Euro Surveill; 2020 Mar; 25(12):. PubMed ID: 32234121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics and outcomes of hospitalised patients with COVID-19 treated in Hubei (epicentre) and outside Hubei (non-epicentre): a nationwide analysis of China.
    Liang WH; Guan WJ; Li CC; Li YM; Liang HR; Zhao Y; Liu XQ; Sang L; Chen RC; Tang CL; Wang T; Wang W; He QH; Chen ZS; Wong SS; Zanin M; Liu J; Xu X; Huang J; Li JF; Ou LM; Cheng B; Xiong S; Xie ZH; Ni ZY; Hu Y; Liu L; Shan H; Lei CL; Peng YX; Wei L; Liu Y; Hu YH; Peng P; Wang JM; Liu JY; Chen Z; Li G; Zheng ZJ; Qiu SQ; Luo J; Ye CJ; Zhu SY; Cheng LL; Ye F; Li SY; Zheng JP; Zhang NF; Zhong NS; He JX
    Eur Respir J; 2020 Jun; 55(6):. PubMed ID: 32269086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-specific SARS-CoV-2 infection fatality ratio and associated risk factors, Italy, February to April 2020.
    Poletti P; Tirani M; Cereda D; Trentini F; Guzzetta G; Marziano V; Buoro S; Riboli S; Crottogini L; Piccarreta R; Piatti A; Grasselli G; Melegaro A; Gramegna M; Ajelli M; Merler S
    Euro Surveill; 2020 Aug; 25(31):. PubMed ID: 32762797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The confounded crude case-fatality rates (CFR) for COVID-19 hide more than they reveal-a comparison of age-specific and age-adjusted CFRs between seven countries.
    Green MS; Peer V; Schwartz N; Nitzan D
    PLoS One; 2020; 15(10):e0241031. PubMed ID: 33085731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China.
    Wu JT; Leung K; Bushman M; Kishore N; Niehus R; de Salazar PM; Cowling BJ; Lipsitch M; Leung GM
    Nat Med; 2020 Apr; 26(4):506-510. PubMed ID: 32284616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19, Australia: Epidemiology Report 18 (Fortnightly reporting period ending 7 June 2020).
    COVID-19 National Incident Room Surveillance Team
    Commun Dis Intell (2018); 2020 Jun; 44():. PubMed ID: 32552623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. History of coronary heart disease increased the mortality rate of patients with COVID-19: a nested case-control study.
    Gu T; Chu Q; Yu Z; Fa B; Li A; Xu L; Wu R; He Y
    BMJ Open; 2020 Sep; 10(9):e038976. PubMed ID: 32948572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case-Fatality Risk Estimates for COVID-19 Calculated by Using a Lag Time for Fatality.
    Wilson N; Kvalsvig A; Barnard LT; Baker MG
    Emerg Infect Dis; 2020 Jun; 26(6):1339-1441. PubMed ID: 32168463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Contribution of the Age Distribution of Cases to COVID-19 Case Fatality Across Countries : A Nine-Country Demographic Study.
    Sudharsanan N; Didzun O; Bärnighausen T; Geldsetzer P
    Ann Intern Med; 2020 Nov; 173(9):714-720. PubMed ID: 32698605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reconstructing the early global dynamics of under-ascertained COVID-19 cases and infections.
    Russell TW; Golding N; Hellewell J; Abbott S; Wright L; Pearson CAB; van Zandvoort K; Jarvis CI; Gibbs H; Liu Y; Eggo RM; Edmunds WJ; Kucharski AJ;
    BMC Med; 2020 Oct; 18(1):332. PubMed ID: 33087179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19, Australia: Epidemiology Report 16 (Reporting week to 23:59 AEST 17 May 2020).
    COVID-19 National Incident Room Surveillance Team
    Commun Dis Intell (2018); 2020 May; 44():. PubMed ID: 32522141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study.
    Clark A; Jit M; Warren-Gash C; Guthrie B; Wang HHX; Mercer SW; Sanderson C; McKee M; Troeger C; Ong KL; Checchi F; Perel P; Joseph S; Gibbs HP; Banerjee A; Eggo RM;
    Lancet Glob Health; 2020 Aug; 8(8):e1003-e1017. PubMed ID: 32553130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Similarity in Case Fatality Rates (CFR) of COVID-19/SARS-COV-2 in Italy and China.
    Porcheddu R; Serra C; Kelvin D; Kelvin N; Rubino S
    J Infect Dev Ctries; 2020 Feb; 14(2):125-128. PubMed ID: 32146445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 107.